GlycoMimetics Statistics
Total Valuation
GlycoMimetics has a market cap or net worth of $13.04 million. The enterprise value is $7.42 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GlycoMimetics has 64.53 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 64.53M |
| Shares Outstanding | 64.53M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | 16.90% |
| Float | 42.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.86 |
| P/TBV Ratio | 3.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.29
| Current Ratio | 2.29 |
| Quick Ratio | 2.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -182.66% and return on invested capital (ROIC) is -90.35%.
| Return on Equity (ROE) | -182.66% |
| Return on Assets (ROA) | -73.99% |
| Return on Invested Capital (ROIC) | -90.35% |
| Return on Capital Employed (ROCE) | -704.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$7.37M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.46% in the last 52 weeks. The beta is 1.60, so GlycoMimetics's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | -25.46% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 34.19 |
| Average Volume (20 Days) | 355,686 |
Short Selling Information
The latest short interest is 1.68 million, so 2.61% of the outstanding shares have been sold short.
| Short Interest | 1.68M |
| Short Previous Month | 1.83M |
| Short % of Shares Out | 2.61% |
| Short % of Float | 3.93% |
| Short Ratio (days to cover) | 3.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.79M |
| Pretax Income | -39.11M |
| Net Income | -29.49M |
| EBITDA | -23.76M |
| EBIT | -23.79M |
| Earnings Per Share (EPS) | -$0.46 |
Full Income StatementBalance Sheet
The company has $5.61 million in cash and n/a in debt, giving a net cash position of $5.61 million or $0.09 per share.
| Cash & Cash Equivalents | 5.61M |
| Total Debt | n/a |
| Net Cash | 5.61M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 3.38M |
| Book Value Per Share | 0.05 |
| Working Capital | 3.38M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.70 million and capital expenditures -$2,533, giving a free cash flow of -$25.70 million.
| Operating Cash Flow | -25.70M |
| Capital Expenditures | -2,533 |
| Free Cash Flow | -25.70M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |